Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223
47 results:

  • 1. Medicinal benefits, biological, and nanoencapsulation functions of riboflavin with its toxicity profile: A narrative review.
    Lee TY; Farah N; Chin VK; Lim CW; Chong PP; Basir R; Lim WF; Loo YS
    Nutr Res; 2023 Nov; 119():1-20. PubMed ID: 37708600
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Construction and validation of a novel Ferroptosis-related gene signature predictive model in rectal cancer.
    Shi WK; Liu YX; Qiu XY; Zhou JY; Zhou JL; Lin GL
    BMC Genomics; 2022 Nov; 23(1):764. PubMed ID: 36414988
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effect of drying method on the production of in vitro short-chain fatty acids and histone deacetylase mediation of cocoa pod husk.
    Nieto-Figueroa KH; Gaytán-Martínez M; Loarca-Piña MGF; Campos-Vega R
    J Food Sci; 2022 Oct; 87(10):4476-4490. PubMed ID: 36102033
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Rare
    Kabbage M; Ben Aissa-Haj J; Othman H; Jaballah-Gabteni A; Laarayedh S; Elouej S; Medhioub M; Kettiti HT; Khsiba A; Mahmoudi M; BelFekih H; Maaloul A; Touinsi H; Hamzaoui L; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011265
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer.
    Hsieh CC; Hsu SH; Lin CY; Liaw HJ; Li TW; Jiang KY; Chiang NJ; Chen SH; Lin BW; Chen PC; Chan RH; Lin PC; Yeh YM; Shen CH
    Br J Cancer; 2022 Nov; 127(9):1615-1628. PubMed ID: 35999268
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes.
    Aldersley J; Lorenz DR; Mouw KW; D'Andrea AD; Gabuzda D
    Mol Cancer Res; 2021 Aug; 19(8):1308-1321. PubMed ID: 33883185
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patient-derived cancer organoid tracking with wide-field one-photon redox imaging to assess treatment response.
    Gil DA; Deming D; Skala MC
    J Biomed Opt; 2021 Mar; 26(3):. PubMed ID: 33754540
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dual modal spectroscopic tissue scanner for colorectal cancer diagnosis.
    Yoon HM; Kim H; Sohn DK; Park SC; Chang HJ; Oh JH; Dasari RR; So PTC; Kang JW
    Surg Endosc; 2021 Aug; 35(8):4363-4370. PubMed ID: 32875410
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Preliminary exploration of robotic complete mesocolic excision for colon cancer with the domestically produced Chinese minimally invasive Micro Hand S surgical robot system.
    Li J; Zhu S; Juan J; Yi B
    Int J Med Robot; 2020 Dec; 16(6):1-8. PubMed ID: 32865308
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking.
    Li L; Li R; Wang Y
    Bioorg Med Chem Lett; 2019 Feb; 29(4):544-548. PubMed ID: 30611617
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identifying molecular contributors to autofluorescence of neoplastic and normal colon sections using excitation-scanning hyperspectral imaging.
    Deal J; Mayes S; Browning C; Hill S; Rider P; Boudreaux C; Rich TC; Leavesley SJ
    J Biomed Opt; 2018 Dec; 24(2):1-11. PubMed ID: 30592190
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The concerted roles of FANCM and Rad52 in the protection of common fragile sites.
    Wang H; Li S; Oaks J; Ren J; Li L; Wu X
    Nat Commun; 2018 Jul; 9(1):2791. PubMed ID: 30022024
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
    Paulo P; Maia S; Pinto C; Pinto P; Monteiro A; Peixoto A; Teixeira MR
    PLoS Genet; 2018 Apr; 14(4):e1007355. PubMed ID: 29659569
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastrointestinal cancers: fad or standard of care?
    Teo MCC; Tan GHC
    Singapore Med J; 2018 Mar; 59(3):116-120. PubMed ID: 29568842
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Lysine-specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC-803.
    Ma JL; Zhang T; Suo FZ; Chang J; Wan XB; Feng XJ; Zheng YC; Liu HM
    J Cell Biochem; 2018 Jun; 119(6):4957-4966. PubMed ID: 29384217
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors.
    Al Abo M; Sasanuma H; Liu X; Rajapakse VN; Huang SY; Kiselev E; Takeda S; Plunkett W; Pommier Y
    Mol Cancer Ther; 2017 Nov; 16(11):2543-2551. PubMed ID: 28802254
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
    Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
    J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
    Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Murgioni S; Rossini D; Marmorino F; Mennitto A; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Yamaguchi T; Loupakis F; Lenz HJ
    Ann Oncol; 2017 May; 28(5):1015-1022. PubMed ID: 28453695
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis.
    Liu C; Gallagher RL; Price GR; Bolton E; Joy C; Harraway J; Venter DJ; Armes JE
    Int J Gynecol Pathol; 2016 Nov; 35(6):561-565. PubMed ID: 27015438
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CRISPR-Cas9-based target validation for p53-reactivating model compounds.
    Wanzel M; Vischedyk JB; Gittler MP; Gremke N; Seiz JR; Hefter M; Noack M; Savai R; Mernberger M; Charles JP; Schneikert J; Bretz AC; Nist A; Stiewe T
    Nat Chem Biol; 2016 Jan; 12(1):22-8. PubMed ID: 26595461
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.